The Growth Imperative: Why The Next Big Pharma Competitor Could Be Google Or Apple

In a seminal work published by McKinsey & Company – The Granularity of Growth, a detailed study of the performance of the 100 largest US corporations over the two most recent business cycles – a key finding emerged: top-line growth is vital for survival. To dig a bit deeper, the study found that a company whose revenue increased slower than the growth of U.S. GDP was five…

Read the full article here

Related Articles